CELLCEPT 250 mg, capsules 100 capsules, parallel import (Laboratoire Mediwin Ldt)
Brand page: CellCept (mycophenolate mofetil) — all forms and strengths in France
Active ingredients: Mycophenolate mofetil
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule100 capsules, parallel import (Laboratoire Mediwin Ldt)orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CELLCEPT 250 mg, gélules
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- 10 plaquette(s) thermoformée(s) PVC-Aluminium de 10 gélule(s) (distributeur parallèle : Laboratoire Mediwin Ldt)
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Jan 2013
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63479642CIP74950448CIP133400949504480Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MYCOPHÉNOLATE MOFÉTILgélule | 250 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.